<code id='BFC843563C'></code><style id='BFC843563C'></style>
    • <acronym id='BFC843563C'></acronym>
      <center id='BFC843563C'><center id='BFC843563C'><tfoot id='BFC843563C'></tfoot></center><abbr id='BFC843563C'><dir id='BFC843563C'><tfoot id='BFC843563C'></tfoot><noframes id='BFC843563C'>

    • <optgroup id='BFC843563C'><strike id='BFC843563C'><sup id='BFC843563C'></sup></strike><code id='BFC843563C'></code></optgroup>
        1. <b id='BFC843563C'><label id='BFC843563C'><select id='BFC843563C'><dt id='BFC843563C'><span id='BFC843563C'></span></dt></select></label></b><u id='BFC843563C'></u>
          <i id='BFC843563C'><strike id='BFC843563C'><tt id='BFC843563C'><pre id='BFC843563C'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:focus    Page View:656
          Cigna Healthcare's logo on a phone
          Adobe

          CVS Health viewed Amy Bricker as a potential CEO. But she won’t be going to the health care conglomerate anytime soon.

          A federal appeals court has ruled Bricker, a former high-ranking executive at Cigna, cannot jump to CVS because it would violate her noncompete agreement that she signed while at Cigna. The appeals court’s decision backs up what a district court had previously ruled.

          advertisement

          The case is a prominent example of why the health care industry, and corporate America writ large, does not want noncompetes to go away. In April, the Federal Trade Commission approved a nationwide ban on most such agreements, which prevent workers from moving to other jobs, but companies and corporate lobbying groups have already sued to squash the ban.

          STAT+ Exclusive Story

          Already have an account? Log in

          STAT+

          This article is exclusive to STAT+ subscribers

          Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.

          Already have an account? Log in

          Already have an account? Log in

          Monthly

          $39

          Totals $468 per year

          $39/month Get Started

          Totals $468 per year

          Starter

          $30

          for 3 months, then $39/month

          $30 for 3 months Get Started

          Then $39/month

          Annual

          $399

          Save 15%

          $399/year Get Started

          Save 15%

          11+ Users

          Custom

          Savings start at 25%!

          Request A Quote Request A Quote

          Savings start at 25%!

          2-10 Users

          $300

          Annually per user

          $300/year Get Started

          $300 Annually per user

          View All Plans

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          ChatGPT in medicine: STAT answers readers' burning questions
          ChatGPT in medicine: STAT answers readers' burning questions

          MikeReddyforSTATArtificialintelligenceisoftendescribedasablackbox:anunknowable,mysteriousforcethatop

          read more
          FDA grants conditional OK to Sarepta’s gene therapy for Duchenne
          FDA grants conditional OK to Sarepta’s gene therapy for Duchenne

          KristofferTripplaar/SipaviaAPTheFoodandDrugAdministrationgrantedconditionalapprovalThursdaytothefirs

          read more
          Supreme Court strikes down use of affirmative action
          Supreme Court strikes down use of affirmative action

          ActivistsdemonstratedastheSupremeCourtheardoralargumentsonapairofaffirmativeactioncasesinOctober2022

          read more

          Death of patient in Alzheimer’s trial raises question of possible risks

          APSTockTheexperimentalAlzheimer’sdruglecanemab,hailedafteritslowedpatients’cognitivedeclineinaclinic